Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder
Place of Origin | China |
---|---|
Brand Name | XRD |
Certification | GMP |
Model Number | 872365-14-5 |
Minimum Order Quantity | negotiable |
Price | Inquiry for Negotiable |
Packaging Details | 1-2 kg / aluminum foil bag, 25kg/ drum, as required |
Delivery Time | 1-2days after payment received |
Payment Terms | T/T bank, Western Union, Bitcoin, Etc |
Supply Ability | 100KG/ Month |

Contact me for free samples and coupons.
Whatsapp:0086 18588475571
Wechat: 0086 18588475571
Skype: sales10@aixton.com
If you have any concern, we provide 24-hour online help.
xCAS | 872365-14-5 | Product Name | Fevipiprant |
---|---|---|---|
Type | Pharmaceutical Intermediate | Appearance | White Powder |
Usage | Muscle Growth | Alias | Fevipiprant |
Assay | 99% | Key Words | Fevipiprant |
High Light | raw materials for pharma industry,pharmaceutical grade raw materials |
Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder
Product Describtion
Fevipiprant Basic information | |
Product Name: | Fevipiprant |
Synonyms: | Fevipiprant;Fevipipran;NVP-QAW039;Fevipiprant(NVP-QAW039);QAW039 |
CAS: | 872365-14-5 |
Appearance | white fine powder |
Key words: | Fevipiprant,NVP-QAW039,QAW039 |
What's the Anti hair loss treatment drug CAS 872365-14-5 fevipiprant bulk NVP-QAW039 powder
Fevipiprant (INN; code name QAW039) is a drug being developed by Novartis which acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2 or CRTh2).
As of 2016, it is in Phase III[4] clinical trials for the treatment of asthma.[5]
Setipiprant (INN) (developmental code names ACT-129,968, KYTH-105) is a drug originally developed by Actelionwhich acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2).[1] It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients,[2][3] it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.
Releated Products for hair loss treatment |
|
| |
RU58841 | CAS 154992-24-2 | Dutasteride | CAS 164656-23-9 |
Setipiprant | CAS 866460-33-5 | S-equol | CAS 531-95-3 |
OC000459 | CAS 851723-84-7 | Minoxidil | CAS 38304-91-5 |
CB-03-01 | CAS 19608-29-8 | Bimatoprost | CAS 155206-00-1 |
Finasteride | CAS 98319-26-7 | Fevipiprant | CAS 872365-14-5 |
Function & Application
Anti hair loss treatment drug CAS 872365-14-5 fevipiprant bulk NVP-QAW039 powder Function
Fevipiprant is the drug for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of Setipiprant have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery.
Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder